Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Subchondral bone lesions can usually be managed nonoperatively. However, once collapse occurs ...

A study of samples from patients with multiple myeloma (MM) has demonstrated how "reprogrammed" fat cells contribute to long-lasting bone damage, even after the cancer has gone into remission.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

Eosinophilic granuloma (EG) is a type of lesion that usually appears on bones. These lesions are caused by an overgrowth of Langerhans cells, which are naturally occurring white blood cells that are ...

A private, clinical-stage biopharma company developing small-molecule–based therapies administered directly to treat ...

Patients with midfoot pain and MRI-detected bone marrow lesions who wore firm foot orthoses achieved greater reductions in pain and bone marrow lesion volume over 12 weeks than those who wore ...

Messenger RNA technology could have broad applications beyond preventing COVID-19 with vaccines. Besides the infectious disease and cancer areas that industry leaders BioNTech and Moderna are already ...

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma Teriparatide treatment was associated with an improved rate of resolution of established MRONJ ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in collaboration with leading German universities, has developed a new biomaterial ...